Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Villasclaras-Fernandez E"'
Autor:
Sanfelice, D., Antolin, A., Crisp, A., Villasclaras-Fernandez, E., Mica, I., Chen, Y., Müller-Knapp, S., Collins, I., Al-Lazikani, B., Edwards, A.M., Workman, P.
Publikováno v:
In European Journal of Cancer October 2022 174 Supplement 1:S83-S83
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Antolin AA; Division of Cancer Therapeutics, The Institute of Cancer Research, London, SM2 5NG, UK.; Department of Data Science, The Institute of Cancer Research, London, SM2 5NG, UK.; Chemical Probes Portal, www.chemicalprobes.org., Sanfelice D; Division of Cancer Therapeutics, The Institute of Cancer Research, London, SM2 5NG, UK.; Department of Data Science, The Institute of Cancer Research, London, SM2 5NG, UK.; Chemical Probes Portal, www.chemicalprobes.org., Crisp A; Division of Cancer Therapeutics, The Institute of Cancer Research, London, SM2 5NG, UK.; Department of Data Science, The Institute of Cancer Research, London, SM2 5NG, UK.; Chemical Probes Portal, www.chemicalprobes.org., Villasclaras Fernandez E; Division of Cancer Therapeutics, The Institute of Cancer Research, London, SM2 5NG, UK.; Department of Data Science, The Institute of Cancer Research, London, SM2 5NG, UK.; Chemical Probes Portal, www.chemicalprobes.org., Mica IL; Division of Cancer Therapeutics, The Institute of Cancer Research, London, SM2 5NG, UK.; Department of Data Science, The Institute of Cancer Research, London, SM2 5NG, UK.; Chemical Probes Portal, www.chemicalprobes.org., Chen Y; Division of Cancer Therapeutics, The Institute of Cancer Research, London, SM2 5NG, UK.; Department of Data Science, The Institute of Cancer Research, London, SM2 5NG, UK.; Chemical Probes Portal, www.chemicalprobes.org., Collins I; Division of Cancer Therapeutics, The Institute of Cancer Research, London, SM2 5NG, UK.; Centre for Cancer Drug Discovery, The Institute of Cancer Research, London, SM2 5NG, UK.; Chemical Probes Portal, www.chemicalprobes.org., Edwards A; Structural Genomics Consortium, University of Toronto, Toronto, ONM5G 1L7, Canada.; Chemical Probes Portal, www.chemicalprobes.org., Müller S; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, 60438, Germany.; Structural Genomics Consortium, BMLS, Goethe University Frankfurt, Frankfurt, 60438, Germany.; Chemical Probes Portal, www.chemicalprobes.org., Al-Lazikani B; Department of Genomics Medicine and the Institute of Data Science in Oncology, MD Anderson Cancer Center, Houston, TX, 77054, USA.; Chemical Probes Portal, www.chemicalprobes.org., Workman P; Division of Cancer Therapeutics, The Institute of Cancer Research, London, SM2 5NG, UK.; Centre for Cancer Drug Discovery, The Institute of Cancer Research, London, SM2 5NG, UK.; Chemical Probes Portal, www.chemicalprobes.org.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2023 Jan 06; Vol. 51 (D1), pp. D1492-D1502.
Autor:
di Micco P; The Department of Genomic Medicine & The Institute of Data Science in Oncology, MD Anderson Cancer Center, Houston, TX, USA.; The Department of Data Science, The Institute of Cancer Research, London, UK., Antolin AA; Centre for Cancer Drug Discovery, The Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Mitsopoulos C; Centre for Cancer Drug Discovery, The Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Villasclaras-Fernandez E; The Department of Data Science, The Institute of Cancer Research, London, UK., Sanfelice D; The Department of Data Science, The Institute of Cancer Research, London, UK.; Centre for Cancer Drug Discovery, The Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Dolciami D; The Department of Data Science, The Institute of Cancer Research, London, UK., Ramagiri P; Centre for Cancer Drug Discovery, The Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Mica IL; The Department of Genomic Medicine & The Institute of Data Science in Oncology, MD Anderson Cancer Center, Houston, TX, USA.; The Department of Data Science, The Institute of Cancer Research, London, UK., Tym JE; The Department of Data Science, The Institute of Cancer Research, London, UK., Gingrich PW; The Department of Genomic Medicine & The Institute of Data Science in Oncology, MD Anderson Cancer Center, Houston, TX, USA., Hu H; Centre for Cancer Drug Discovery, The Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Workman P; Centre for Cancer Drug Discovery, The Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Al-Lazikani B; The Department of Genomic Medicine & The Institute of Data Science in Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2023 Jan 06; Vol. 51 (D1), pp. D1212-D1219.
Autor:
Dolciami D; Department of Data Science, The Institute of Cancer Research, London, SM2 5NG, UK.; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SM2 5NG, UK.; BenevolentAI, London, W1T 5HD, UK., Villasclaras-Fernandez E; Department of Data Science, The Institute of Cancer Research, London, SM2 5NG, UK., Kannas C; Molecular AI, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Meniconi M; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SM2 5NG, UK.; Dunad therapeutics, Cambridge, UK., Al-Lazikani B; MD Anderson Cancer Center, Houston, TX, 77054, USA. ballazikani@mdanderson.org., Antolin AA; Department of Data Science, The Institute of Cancer Research, London, SM2 5NG, UK. Albert.Antolin@icr.ac.uk.; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SM2 5NG, UK. Albert.Antolin@icr.ac.uk.
Publikováno v:
Journal of cheminformatics [J Cheminform] 2022 May 28; Vol. 14 (1), pp. 28. Date of Electronic Publication: 2022 May 28.
Autor:
Coker EA; Department of Data Science, The Institute of Cancer Research, London SM2 5NG, UK., Mitsopoulos C; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, UK., Tym JE; Department of Data Science, The Institute of Cancer Research, London SM2 5NG, UK., Komianou A; Department of Data Science, The Institute of Cancer Research, London SM2 5NG, UK., Kannas C; Department of Data Science, The Institute of Cancer Research, London SM2 5NG, UK., Di Micco P; Department of Data Science, The Institute of Cancer Research, London SM2 5NG, UK., Villasclaras Fernandez E; Department of Data Science, The Institute of Cancer Research, London SM2 5NG, UK., Ozer B; Department of Data Science, The Institute of Cancer Research, London SM2 5NG, UK.; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, UK., Antolin AA; Department of Data Science, The Institute of Cancer Research, London SM2 5NG, UK., Workman P; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, UK., Al-Lazikani B; Department of Data Science, The Institute of Cancer Research, London SM2 5NG, UK.; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, UK.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2019 Jan 08; Vol. 47 (D1), pp. D917-D922.